Replacement Therapy ERT — What It Is and How It Works in Practice
Replacement Therapy ERT is endocrine replacement therapy. It replaces a hormone your body can no longer produce at adequate levels. Most commonly this refers to thyroid hormone replacement (levothyroxine) or corticosteroid replacement in adrenal insufficiency. The specifics depend entirely on which gland is involved, what the deficient hormone is, and how you are monitoring the patient over time. I have seen more damage done by lazy dosing than by the deficiency itself. The hormone isn't something you can adjust weekly based on how you feel. It requires steady-state tracking, proper lab timing, and patience. Starting dose, titration intervals, and target ranges vary by condition. The principle is straightforward: identify the missing or deficient hormone, calculate an initial replacement dose based on weight or clinical guidelines, start low, and adjust using lab values measured after steady state is reached. For thyroid hormone, that means checking TSH and free T4 roughly 6–8 weeks after any dose change. For adrenal replacement, you are often looking at symptom control, blood pressure, electrolytes, and occasionally renin or cortisol rhythms depending on the protocol your clinician follows.
What people miss is the timing. Levothyroxine, for example, must be taken on an empty stomach with water alone. Food, calcium, iron, and even coffee can reduce absorption by 20–40 percent in different patients. I once had a patient who thought she was non-compliant because her labs never improved. She was taking her pill with her morning protein shake. We moved it to first thing in the morning with water and her TSH normalized within two cycles. Never underestimate interaction effects.
Common Pitfalls
Over-replacement is a real risk, especially with thyroid hormone. Suppressed TSH beyond what is targeted increases bone loss risk and can trigger atrial fibrillation in older patients. Under-replacement leaves the original symptoms intact. Both outcomes are preventable with regular monitoring and clear communication with your prescriber. Another issue is brand switching. Different manufacturers use different fillers and binders. Some patients report symptom changes between generics, and there is documented variability in bioavailability between brands. If your numbers were stable on one formulation and you get switched, recheck labs before declaring the new version ineffective.
Get the Full Details
When It Doesn't Work Well
Replacement therapy is not a cure. It manages the deficiency. If the underlying cause involves malabsorption, autoimmune activity, or surgical removal, the hormone level will only be correct as long as dosing is continuously optimized. Compliance gaps, drug interactions, pregnancy, and weight changes all shift requirements. This is not a set-it-and-forget-it treatment. For some patients, combination therapy (T3 plus T4) is discussed when standard levothyroxine monotherapy does not resolve symptoms despite normal labs. The evidence is mixed. Some patients report benefit; others do not. This is a decision for an endocrinologist, not something to self-adjust.
Bottom Line
Replacement Therapy ERT is established, well-studied, and effective when managed properly. The main dangers are impatience with dosing adjustments, ignoring interaction effects, and assuming stability without periodic lab checks. Work with a clinician who monitors appropriately and communicates clearly about targets and timelines. That is usually the difference between a smooth course and a months-long adjustment phase.
